Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This innovative therapy has helped people lose weight and maintain their results
D1-D2 receptor heteromers are highly expressed in NAc and have been shown to enhance BDNF expression and signal transduction in NAc (Shen et al., 2015)
Competing interests DB received presentation fees (TEVA, Novartis and Pfizer), travel fees (Allergan, TEVA, Pfizer, Abbvie and Lundbeck), advisory board fees (Novartis, Lilly, Teva, Lundbeck, Pfizer and Abbvie) and participated in clinical trials (TEVA, Lundbeck, Novartis, Lilly and Novo Nordisk Foundation) outside of the submitted work
Discussion This prospective study was the first to evaluate the effects of oral semaglutide treatment in obese people receiving antipsychotic medication
US$ 23.64
US$ 28.60
US$ 23.66
US$ 27.47
